621 related articles for article (PubMed ID: 22121248)
1. Antiplatelets in secondary stroke prevention: should clopidogrel be the first choice?
Aw D; Sharma JC
Postgrad Med J; 2012 Jan; 88(1035):34-7. PubMed ID: 22121248
[TBL] [Abstract][Full Text] [Related]
2. Combination antiplatelet agents for secondary prevention of ischemic stroke.
Vande Griend JP; Saseen JJ
Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
[TBL] [Abstract][Full Text] [Related]
3. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
Kirshner HS
Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
[TBL] [Abstract][Full Text] [Related]
5. Current guidelines on antiplatelet agents for secondary prevention of noncardiogenic stroke: an evidence-based review.
Simmons BB; Yeo A; Fung K; ;
Postgrad Med; 2010 Mar; 122(2):49-53. PubMed ID: 20203455
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelets and stroke outcomes: state of the science.
Meyer D
Crit Care Nurs Clin North Am; 2009 Dec; 21(4):517-28. PubMed ID: 19951767
[TBL] [Abstract][Full Text] [Related]
7. Prevention of ischaemic stroke--antiplatelets.
McCabe DJ; Brown MM
Br Med Bull; 2000; 56(2):510-25. PubMed ID: 11092100
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet agents and randomized trials.
Diener HC
Rev Neurol Dis; 2007; 4(4):177-83. PubMed ID: 18195669
[TBL] [Abstract][Full Text] [Related]
9. Review and management of side effects associated with antiplatelet therapy for prevention of recurrent cerebrovascular events.
Guthrie R
Adv Ther; 2011 Jun; 28(6):473-82. PubMed ID: 21547541
[TBL] [Abstract][Full Text] [Related]
10. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
Diener HC
Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062
[TBL] [Abstract][Full Text] [Related]
11. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
Hankey GJ
Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
[TBL] [Abstract][Full Text] [Related]
12. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view.
Gebel JM
J Am Coll Cardiol; 2005 Sep; 46(5):752-5. PubMed ID: 16139120
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
14. Secondary prevention in the acute and early chronic phase after ischaemic stroke and transient ischaemic attacks with antiplatelet drugs--is antiplatelet monotherapy still reasonable?
Diener HC; Weber R; Weimar C; Röther J
Int J Clin Pract; 2011 May; 65(5):531-5. PubMed ID: 21489077
[No Abstract] [Full Text] [Related]
15. Secondary prevention of ischaemic stroke and TIA.
Diener HC
Cardiovasc J Afr; 2008; 19(4):229. PubMed ID: 18776974
[No Abstract] [Full Text] [Related]
16. MATCH results: implications for the internist.
Lutsep HL
Am J Med; 2006 Jun; 119(6):526.e1-7. PubMed ID: 16750967
[TBL] [Abstract][Full Text] [Related]
17. Newer antiplatelet therapies in stroke prevention.
Davis SM; Donnan GA
Aust Fam Physician; 2001 Feb; 30(2):129-34. PubMed ID: 11280112
[TBL] [Abstract][Full Text] [Related]
18. Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.
Jamieson DG; Parekh A; Ezekowitz MD
J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):153-61. PubMed ID: 16211203
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet therapy in cerebrovascular disorders.
Weber R; Brenck J; Diener HC
Handb Exp Pharmacol; 2012; (210):519-46. PubMed ID: 22918745
[TBL] [Abstract][Full Text] [Related]
20. Evolving perspectives on clopidogrel in the treatment of ischemic stroke.
Gorelick P; Sechenova O; Hennekens CH
J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):245-8. PubMed ID: 17220470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
